5-110528736-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039763.4(TMEM232):āc.1555A>Gā(p.Ile519Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000437 in 1,534,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039763.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM232 | ENST00000455884.7 | c.1555A>G | p.Ile519Val | missense_variant | 12/14 | 2 | NM_001039763.4 | ENSP00000401477.2 | ||
TMEM232 | ENST00000512003.7 | n.*997+39711A>G | intron_variant | 1 | ENSP00000427785.2 | |||||
TMEM232 | ENST00000515518.6 | n.1375+39711A>G | intron_variant | 1 | ||||||
TMEM232 | ENST00000508571.6 | n.1018+39711A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151940Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000164 AC: 22AN: 133824Hom.: 0 AF XY: 0.000233 AC XY: 17AN XY: 72904
GnomAD4 exome AF: 0.0000427 AC: 59AN: 1382610Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 46AN XY: 682240
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.1555A>G (p.I519V) alteration is located in exon 12 (coding exon 11) of the TMEM232 gene. This alteration results from a A to G substitution at nucleotide position 1555, causing the isoleucine (I) at amino acid position 519 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at